Next Article in Journal
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma
Next Article in Special Issue
Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
Previous Article in Journal
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
Previous Article in Special Issue
Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in “Immune Desert” NSCLC
 
 
Article

Article Versions Notes

Cancers 2021, 13(9), 2041; https://doi.org/10.3390/cancers13092041
Action Date Notes Link
article xml file uploaded 23 April 2021 12:06 CEST Original file -
article xml uploaded. 23 April 2021 12:06 CEST Update -
article pdf uploaded. 23 April 2021 12:06 CEST Version of Record https://www.mdpi.com/2072-6694/13/9/2041/pdf-vor
article supplementary file uploaded. 23 April 2021 12:06 CEST - https://www.mdpi.com/2072-6694/13/9/2041#supplementary
article html file updated 23 April 2021 12:07 CEST Original file -
article xml file uploaded 25 April 2021 08:16 CEST Update -
article xml uploaded. 25 April 2021 08:16 CEST Update https://www.mdpi.com/2072-6694/13/9/2041/xml
article pdf uploaded. 25 April 2021 08:16 CEST Updated version of record https://www.mdpi.com/2072-6694/13/9/2041/pdf
article html file updated 25 April 2021 08:18 CEST Update -
article html file updated 26 July 2022 16:30 CEST Update https://www.mdpi.com/2072-6694/13/9/2041/html
Back to TopTop